Suspected Interstitial Lung Disease in COPDGene Study

Abstract

<b>Rationale:</b> Although interstitial lung abnormalities (ILA), specific patterns of incidentally-detected abnormal density on computed tomography, have been associated with abnormal lung function and increased mortality, it is unclear if a subset with incidental interstitial lung disease (ILD) accounts for these adverse consequences. <b>Objectives:</b> To define the prevalence and risk factors of suspected ILD and assess outcomes. <b>Methods:</b> Suspected ILD was evaluated in the COPDGene (Chronic Obstructive Pulmonary Disease Genetic Epidemiology) study, defined as ILA and at least one additional criterion: definite fibrosis on computed tomography, FVC less than 80% predicted, or DL_CO less than 70% predicted. Multivariable linear, longitudinal, and Cox proportional hazards regression models were used to assess associations with St. George's Respiratory Questionnaire, 6-minute-walk test, supplemental oxygen use, respiratory exacerbations, and mortality. <b>Measurements and Main Results:</b> Of 4,361 participants with available data, 239 (5%) had evidence for suspected ILD, whereas 204 (5%) had ILA without suspected ILD. In multivariable analyses, suspected ILD was associated with increased St. George's Respiratory Questionnaire score (mean difference [MD], 3.9 points; 95% confidence interval [CI], 0.6-7.1; <i>P</i> = 0.02), reduced 6-minute-walk test (MD, -35 m; 95% CI, -56 m to -13 m; <i>P</i> = 0.002), greater supplemental oxygen use (odds ratio [OR], 2.3; 95% CI, 1.1-5.1; <i>P</i> = 0.03) and severe respiratory exacerbations (OR, 2.9; 95% CI, 1.1-7.5; <i>P</i> = 0.03), and higher mortality (hazard ratio, 2.4; 95% CI, 1.2-4.6; <i>P</i> = 0.01) compared with ILA without suspected ILD. Risk factors associated with suspected ILD included self-identified Black race (OR, 2.0; 95% CI, 1.1-3.3; <i>P</i> = 0.01) and pack-years smoking history (OR, 1.2; 95% CI, 1.1-1.3; <i>P</i> = 0.0005). <b>Conclusions:</b> Suspected ILD is present in half of those with ILA in COPDGene and is associated with exercise decrements and increased symptoms, supplemental oxygen use, severe respiratory exacerbations, and mortality.